Pharma-Bio Serv Q3 revenue $2.0M (down 17% YoY); net loss narrows to $0.2M

Pharma-Bio Serv, Inc.

2025-Q3 EPS reported $0.00 revenue$6,851,460

Revenue for three months ended July 31, 2025 was $2.0M, down from $2.4M in the same period last year.
Net loss for Q3 was $0.2M, an improvement of $0.1M compared to a $0.3M loss in Q3 2024.
Nine-month revenue was $6.9M vs $7.2M YoY; net loss $0.1M, improvement of $0.7M.
CEO cites cost streamlining and preparation for imminent start of several significant projects.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.